Jan 22 2026HEALTH
Vaccine Study in Guinea-Bissau: What's the Hold-Up?
A vaccine study in Guinea-Bissau, funded by the U. S. , is currently on hold. The study aims to compare the health outcomes of newborns who receive the hepatitis B vaccine at birth versus those who get it at six weeks. This has sparked debate among experts. The study's future is uncertain. Guinea-B
reading time less than a minute
